Leveraging Multimodal Foundation Models in Biliary Tract Cancer Research

Area of Science:

• Artificial Intelligence
• Oncology
• Medical Informatics

Background:

• Biliary tract cancers (BTCs) are aggressive, rare malignancies with poor prognoses and diagnostic challenges.
• Distinct BTC subtypes (iCCA, pCCA, dCCA) require tailored research approaches.
• Multimodal foundation models (MFMs) offer a novel framework for integrating complex BTC data.

Purpose of the Study:

• To explore the transformative potential of MFMs in biliary tract cancer (BTC) research.
• To identify key applications of MFMs in understanding and treating distinct BTC subtypes.
• To outline challenges and future directions for MFMs in BTC research.

Main Methods:

• Review of current literature on MFMs and their application in cancer research.
• Analysis of MFMs' capabilities in integrating radiological, histopathological, multi-omics, and clinical data.
• Exploration of potential applications including biomarker discovery, diagnostics, drug repurposing, and patient stratification.

Main Results:

• MFMs can integrate diverse data types for BTC research, potentially enhancing biomarker discovery and patient stratification.
• Applications include improving diagnostic accuracy and accelerating drug repurposing for distinct BTC subtypes.
• Significant challenges remain, including data scarcity, computational demands, and clinical integration.

Conclusions:

• MFMs offer promising avenues for advancing BTC research, particularly for distinct subtypes like iCCA and pCCA.
• Clinical validation and prospective trials are essential for evidence-based adoption, with an estimated timeline of 7-10 years.
• AI-driven methodologies, including MFMs, represent a significant future direction for tackling challenging BTCs.